Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Tiburio Therapeutics
700 Technology Square, 2nd Fl
Cambridge, MA 02139
Phone: 617-231-6050
www.tiburio.com

Tiburio is a clinical stage biopharmaceutical company dedicated to advancing novel treatments for rare neuroendocrine tumors and rare endocrine diseases where there is significant patient need. Our pipeline consists of two clinical stage compounds, TBR-760 for the treatment of non-functioning pituitary adenoma (NFPA) and TBR-065 for additional rare endocrine diseases. The company was launched out of orphan drug accelerator Cydan with financing from leading life sciences investors.

Key Contact
Name
Abraham Ceesay
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/03/19 $31,000,000 Series A Alexandria Venture Investments
Longitude Capital
Lundbeckfonden Ventures
New Enterprise Associates
undisclosed


Featured Reading